Repository logo
 
Publication

Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation

dc.contributor.authorOliveira, Luis MA
dc.contributor.authorLages, Ana
dc.contributor.authorGomes, Ricardo A
dc.contributor.authorNeves, Henrique
dc.contributor.authorFamília, Carlos
dc.contributor.authorCoelho, Ana V
dc.contributor.authorQuintas, Alexandre
dc.date.accessioned2013-10-25T15:01:27Z
dc.date.available2013-10-25T15:01:27Z
dc.date.issued2011
dc.description.abstractBackground: Insulin is a hormone that regulates blood glucose homeostasis and is a central protein in a medical condition termed insulin injection amyloidosis. It is intimately associated with glycaemia and is vulnerable to glycation by glucose and other highly reactive carbonyls like methylglyoxal, especially in diabetic conditions. Protein glycation is involved in structure and stability changes that impair protein functionality, and is associated with several human diseases, such as diabetes and neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease and Familiar Amyloidotic Polyneuropathy. In the present work, methylglyoxal was investigated for their effects on the structure, stability and fibril formation of insulin.por
dc.description.abstractResults: Methylglyoxal was found to induce the formation of insulin native-like aggregates and reduce protein fibrillation by blocking the formation of the seeding nuclei. Equilibrium-unfolding experiments using chaotropic agents showed that glycated insulin has a small conformational stability and a weaker dependence on denaturant concentration (smaller m-value). Our observations suggest that methylglyoxal modification of insulin leads to a less compact and less stable structure that may be associated to an increased protein dynamics.por
dc.description.abstractConclusions: We propose that higher dynamics in glycated insulin could prevent the formation of the rigid crossb core structure found in amyloid fibrils, thereby contributing to the reduction in the ability to form fibrils and to the population of different aggregation pathways like the formation of native-like aggregates.por
dc.identifier.citationBMC Biochemistry 2011, 12:41por
dc.identifier.doi10.1186/1471-2091-12-41
dc.identifier.issn1471-2091
dc.identifier.urihttp://hdl.handle.net/10400.26/4824
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherBioMed Central Ltdpor
dc.relationToward an understanding of protein glycation in Parkinson's disease: in vitro and in vivo studies of folding, aggregation and degradation pathways of alpha-synuclein, synphilin-1 and parkin under glycation conditions.
dc.relationMECANISMO MOLECULAR DE AGREGAÇÃO DA ALFA-SINUCLEÍNA E SUAS VARIANTES NA DOENÇA DE PARKINSON: DESENVOLVI- MENTO DE NOVAS ESTRATÉGIAS TERAPÊUTICAS
dc.relation.publisherversionhttp://www.biomedcentral.com/1471-2091/12/41por
dc.subjectInsulinapor
dc.titleInsulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formationpor
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleToward an understanding of protein glycation in Parkinson's disease: in vitro and in vivo studies of folding, aggregation and degradation pathways of alpha-synuclein, synphilin-1 and parkin under glycation conditions.
oaire.awardTitleMECANISMO MOLECULAR DE AGREGAÇÃO DA ALFA-SINUCLEÍNA E SUAS VARIANTES NA DOENÇA DE PARKINSON: DESENVOLVI- MENTO DE NOVAS ESTRATÉGIAS TERAPÊUTICAS
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI%2F73430%2F2006/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F23604%2F2005/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F41037%2F2007/PT
oaire.citation.titleBMC Biochemistrypor
oaire.citation.volume12por
oaire.fundingStream3599-PPCDT
oaire.fundingStreamSFRH
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isProjectOfPublicationadc34721-a4f0-4f0a-8a7c-cf54687c08ab
relation.isProjectOfPublication4d4bd6ea-87de-46a2-b3b9-6e7e7f9f7506
relation.isProjectOfPublication87b7d8c4-a059-44f9-acf4-8a1dedff9e8c
relation.isProjectOfPublication.latestForDiscoveryadc34721-a4f0-4f0a-8a7c-cf54687c08ab

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1471-2091-12-41.pdf
Size:
976.47 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description: